The U.S. headquarters for Roche Diagnostics is located in Indianapolis. (photo courtesy of Roche Diagnostics)

The U.S. Department of Defense has awarded a $340 million contract to Roche Diagnostics in Indianapolis. The contract calls for the production of COVID-19 rapid antigen tests for the U.S. Army.

Work will be performed in Indianapolis. The project has an estimated completion date of March 14.

The contract is being funded by American Rescue Plan Act funds. The contracting activity is U.S. Army Contracting Command, Aberdeen Proving Ground in Maryland.